TCL Archive CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years April 16, 1999
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested February 11, 1977
TCL Archive Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses May 31, 2013
